Program Status

Programs

Pathogen

Inactivation

Studies

Toxicology

Studies

Clinicals

Platelet

Complete

Complete

Plasma

Complete

Complete

Phase III in process

RBC

In Process

In Process

Phase III trials complete. Awaiting CE Mark and FDA approval

Phase III in process

Europe 2000

U.S. 2001

Europe 2002

U.S. 2002

Europe 2003

U.S. 2003

Expected

Modular Filing

Dates

Previous slide

Next slide

Back to first slide

View graphic version